Scientists uncover new driver of ovarian cancer spread

Adelaide researchers have identified a promising new biomarker and treatment target for ovarian cancer that could markedly improve the outlook for women diagnosed with this aggressive disease. Ovarian cancer is the most lethal gynaecological cancer in the world with a very poor survival rate, mainly due to late diagnosis. Each year, more than 200,000 women die from ovarian cancer, with about 70% of cases only discovered at advanced stages when the disease has spread beyond the ovaries. Lead researcher Dr Hugo Albrecht, from UniSA’s Centre for Pharmaceutical Innovation, says that F2R is frequently overexpressed in ovarian cancer tissues, especially in women who are resistant to chemotherapy and where the cancer has spread. For more from University of South Australia visit: UniSA Homepage: https://www.unisa.edu.au/ UniSA Facebook: https://www.facebook.com/UniSA/ UniSA Twitter (X): https://twitter.com/UniversitySA UniSA Instagram: https://www.instagram.com/universitysa/ UniSA Weibo: http://weibo.com/studyatunisa CRICOS provider number 00121B / Australian University provider number PRV12107 For more from University of South Australia visit: UniSA Homepage: https://www.unisa.edu.au/ UniSA Facebook: https://www.facebook.com/UniSA/ UniSA Twitter (X): https://twitter.com/UniversitySA UniSA Instagram: https://www.instagram.com/universitysa/ UniSA Weibo: http://weibo.com/studyatunisa CRICOS provider number 00121B / Australian University provider number PRV12107